Literature DB >> 6217084

Activation of complement via the alternative pathway.

M K Pangburn.   

Abstract

Activation of complement via the alternative pathway represents one means of natural resistance to infection because it is capable of neutralizing a wide variety of potential pathogens in the total absence of antibody. The pathway involves six serum proteins and possesses a unique amplification system capable of depositing large numbers of C3b molecules on the surfaces of activating particles. C3b deposition enhances phagocytosis and results in activation of the membrane attack pathway of complement. C3b attachment is covalent, arising from a reaction between an intramolecular thiolester bond in nascent C3b and nucleophiles such as hydroxyl groups on surface carbohydrates. The reactions that initiate C3b attachment are not specific interactions like those initiating other biological cascade systems, but involve slow, spontaneous hydrolysis of the thiolester bond in C3 and subsequent random deposition of C3b onto all nearby surfaces. Once bound, C3b is capable of discriminating between host-derived cells and activating particles. Recognition is evidenced by a lower affinity between activator-bound C3b and the complement control protein factor H. Measurements of the association constant between unbound, soluble C3b and factor H suggest that activator-bound C3b recognizes structures on activators that inhibit factor H binding.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6217084

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  14 in total

Review 1.  Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation.

Authors:  Hans U Lutz; Peter J Späth
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  The pathogenesis of hyaline arteriolosclerosis.

Authors:  C N Gamble
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

3.  Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.

Authors:  S Merino; X Rubires; A Aguilar; S Albertí; S Hernandez-Allés; V J Benedí; J M Tomas
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 4.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica.

Authors:  E Wachter; V Brade
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.

Authors:  B Ciurana; J M Tomás
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway.

Authors:  Rosario Fernandez-Godino; Kinga M Bujakowska; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

8.  Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.

Authors:  Sarah E Sartain; Nancy A Turner; Joel L Moake
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

9.  Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.